Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Death domain-containing protein 1 (DTHD1) is a poorly characterized protein encoded by the DTHD1 gene located on chromosome 4p14. The protein contains a canonical death domain, a protein-protein interaction domain found in many proteins that mediate apoptosis and intracellular signaling complex formation. Although death domain-containing proteins often participate in signal transduction, apoptosis, and inflammatory pathways, there is currently no specific evidence that DTHD1 is a validated therapeutic target or that it directly interacts with drugs or established cell signaling networks. Alternative splicing produces multiple transcript variants. In disease, DTHD1 has been associated in some reports with aniridia 1 and Leber Plus disease, but the connection is not well established and overall evidence for its direct involvement in human pathology remains limited. The broader protein superfamily (death domain proteins) is established as functionally important in apoptosis, inflammation, and immune response, but DTHD1 itself has not been directly linked to these processes in detail.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Death domain-containing protein 1 (DTHD1).